Lenox Hill Pathology P C

Lenox Hill Pathology P C shows consistent revenue growth but reports zero officer compensation across all filings.

EIN: 133644370 · Westbury, NY · NTEE: E11 · Updated: 2026-03-28

$6.9MRevenue
$423KAssets
70/100Mission Score (Good)
E11
Lenox Hill Pathology P C Financial Summary
MetricValue
Total Revenue$6.9M
Total Expenses$7.0M
Program Spending90%
CEO/Top Officer Pay$7
Net Assets$321K
Transparency Score70/100

Is Lenox Hill Pathology P C Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
3 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Lenox Hill Pathology P C directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Lenox Hill Pathology P C

Lenox Hill Pathology P C (EIN: 133644370) is a nonprofit organization based in Westbury, NY, classified under NTEE code E11. The organization reported total revenue of $6.9M and total assets of $423K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Lenox Hill Pathology P C's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

8Years Operating
Mid-SizeSize Classification
6Years of Filings
GrowingRevenue Trajectory

Lenox Hill Pathology P C is a mid-size nonprofit that has been operating for 8 years, with 6 years of IRS 990 filings on record (2018–2023). Revenue has grown at a compound annual rate of 14.3%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$7.0M
Total Expenses$7.0M
Surplus / Deficit+$0
Total Assets$341K
Total Liabilities$20K
Net Assets$321K
Operating Margin0.0%
Debt-to-Asset Ratio5.8%
Months of Reserves0.6 months

Financial Health Grade: B

In 2023, Lenox Hill Pathology P C reported a surplus of $0 with revenue exceeding expenses, holds 0.6 months of operating reserves (limited), has a debt-to-asset ratio of 5.8% (very low leverage).

Financial Trends

Over 6 years of filings (2018–2023), Lenox Hill Pathology P C's revenue has grown at a compound annual growth rate (CAGR) of 14.3%.

YearRevenue ChangeExpense ChangeAsset Change
2023+8.4%+8.4%+6.0%
2022+3.2%+10.3%-6.1%
2021+16.1%+11.2%+379.2%
2020+3.9%+1.4%+9652.7%
2019+44.3%+40.7%-99.2%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date2018

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

Lenox Hill Pathology P C demonstrates consistent revenue growth over the past six years, increasing from $3.58 million in 2018 to $6.98 million in 2023. However, the organization consistently reports zero officer compensation, which is unusual for an entity of its size and revenue, potentially indicating that key personnel are compensated through other means or that the entity operates in a unique structure not fully captured by standard 990 reporting for officer compensation. The organization's assets have fluctuated, showing a significant drop from $732,000 in 2019 to $71,390 in 2020, then recovering to $340,590 by 2023. The consistent reporting of expenses matching revenue in 2022 and 2023 suggests a break-even operational model, which can be efficient but leaves little room for building reserves or investing in future growth. The NTEE code E11 (Medical Research) suggests a program-heavy operational model, but without detailed expense breakdowns, it's difficult to fully assess spending efficiency.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Lenox Hill Pathology P C with a Mission Score of 70 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 10%
  • programs: 90%
  • fundraising: 0%

According to IRS 990 filings, Lenox Hill Pathology P C allocates its expenses as follows: admin: 10%, programs: 90%, fundraising: 0%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$7.0MTotal Revenue
$7.0MTotal Expenses
$341KTotal Assets
$20KTotal Liabilities
$321KNet Assets
  • The organization reported a surplus of $0, with revenue exceeding expenses.
  • Debt-to-asset ratio: 5.8%.

Executive Compensation Analysis

The organization consistently reports 0% officer compensation across all six filings, which is highly unusual for an entity with annual revenues approaching $7 million. This lack of reported compensation could indicate that executives are compensated through a related for-profit entity or as contractors, rather than as employees, which limits transparency regarding leadership costs.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Lenox Hill Pathology P C's IRS 990 filings:

  • Consistent reporting of zero officer compensation despite significant revenue, reducing transparency.
  • Significant fluctuation in assets, particularly the drop from $732,000 in 2019 to $71,390 in 2020, without clear explanation.
  • High liabilities relative to assets in 2018 ($650,434 liabilities vs. $93,083 assets).

Strengths

The following positive indicators were identified for Lenox Hill Pathology P C:

  • Consistent and strong revenue growth from $3.58 million in 2018 to $6.98 million in 2023.
  • Apparent operational efficiency in 2022 and 2023 with expenses matching revenue.
  • NTEE code E11 (Medical Research) suggests a focus on a critical program area.

Frequently Asked Questions about Lenox Hill Pathology P C

Is Lenox Hill Pathology P C a legitimate charity?

Lenox Hill Pathology P C (EIN: 133644370) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 70/100. It has 6 years of IRS 990 filings on record. Total revenue: $6.9M. 3 red flags identified. 3 strengths noted. Financial health grade: B.

How does Lenox Hill Pathology P C spend its money?

Lenox Hill Pathology P C directs 90% of its spending to programs and services. This exceeds the 65% industry benchmark.

Are donations to Lenox Hill Pathology P C tax-deductible?

Lenox Hill Pathology P C is registered as a tax-exempt nonprofit (EIN: 133644370). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

How much does the Lenox Hill Pathology P C CEO make?

Lenox Hill Pathology P C's highest-compensated officer earns $7 annually. The organization reported $6.9M in total revenue. Executive compensation data is disclosed in IRS 990 filings.

How does Lenox Hill Pathology P C compare to similar nonprofits?

With a transparency score of 70/100 (Good), Lenox Hill Pathology P C is above average for NTEE category E11 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is Lenox Hill Pathology P C located?

Lenox Hill Pathology P C is headquartered in Westbury, New York and files with the IRS under EIN 133644370. It is classified under NTEE code E11.

How many years of IRS 990 filings does Lenox Hill Pathology P C have?

Lenox Hill Pathology P C has 6 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $6.9M in total revenue.

Why is officer compensation consistently reported as $0?

The IRS 990 filings for Lenox Hill Pathology P C consistently report $0 for officer compensation, despite the organization's significant and growing revenue. This could be due to officers being compensated as independent contractors, through a related for-profit entity, or through other non-reportable means, which reduces transparency regarding executive pay.

What is the nature of the organization's liabilities, particularly the $650,434 reported in 2018?

In 2018, Lenox Hill Pathology P C reported liabilities of $650,434, which was significantly higher than its assets of $93,083. While liabilities have since decreased substantially, the nature of this large liability and its resolution is not detailed in the summary data, raising questions about financial stability during that period.

How does the organization manage to consistently break even, as seen in 2022 and 2023 where expenses equal revenue?

In 2022 and 2023, Lenox Hill Pathology P C reported expenses exactly matching revenue. While this indicates efficient budgeting, it also suggests a lack of surplus for building reserves or investing in future growth, which could impact long-term financial resilience.

Filing History

IRS 990 filing history for Lenox Hill Pathology P C showing financial trends over 6 years of public records:

Over 6 years of IRS 990 filings (2018–2023), Lenox Hill Pathology P C's revenue has grown by 94.7%, moving from $3.6M to $7.0M. Total assets increased by 265.9% over the same period, from $93K to $341K. Total functional expenses rose by 89.6%, from $3.7M to $7.0M. In its most recent filing year (2023), Lenox Hill Pathology P C reported a surplus of $0, with revenue exceeding expenses. The organization holds $20K in liabilities against $341K in assets (debt-to-asset ratio: 5.8%), resulting in net assets of $321K.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $7.0M $7.0M $341K $20K
2022 $6.4M $6.4M $321K $1K View 990
2021 $6.2M $5.8M $342K $22K View 990
2020 $5.4M $5.2M $71K $34K View 990
2019 $5.2M $5.2M $732 $19K View 990
2018 $3.6M $3.7M $93K $650K View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $7.0M, expenses of $7.0M, and assets of $341K (revenue +8.4% year-over-year).
  • 2022: Revenue of $6.4M, expenses of $6.4M, and assets of $321K (revenue +3.2% year-over-year).
  • 2021: Revenue of $6.2M, expenses of $5.8M, and assets of $342K (revenue +16.1% year-over-year).
  • 2020: Revenue of $5.4M, expenses of $5.2M, and assets of $71K (revenue +3.9% year-over-year).
  • 2019: Revenue of $5.2M, expenses of $5.2M, and assets of $732 (revenue +44.3% year-over-year).
  • 2018: Revenue of $3.6M, expenses of $3.7M, and assets of $93K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Lenox Hill Pathology P C:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing

Data Sources and Methodology

This transparency report for Lenox Hill Pathology P C is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New York

Explore more nonprofits based in New York with AI-powered transparency reports.

View all New York nonprofits →

Similar Organizations (NTEE E11)

Other nonprofits classified under NTEE code E11.

View all E11 nonprofits →

Explore Related Nonprofits

Browse by State